Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication - DREAM - Rosiglitazone

Description:

The goal of the trial was to evaluate treatment with rosiglitazone compared with placebo among patients without cardiovascular disease or a history of diabetes but with impaired glucose.